Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine
Clinical trial NCT04485702 · COMPLETED
Trial details
- NCT number
- NCT04485702
- Sponsor
- Melt Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2020-08-29
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.